Unlike injectable versions that bypass the digestive tract entirely, oral medications must navigate stomach acid and the intestinal barrier, which is why dosing schedules and food interactions matter significantly
The study reported that the 60 mg/day dose significantly reduced lipid peroxidation and improved antioxidant status (Mousavinejad et al., 2018)
14,15 Because of the results of these landmark clinical trials, evidence-based treatment guidelines now recommend the GLP-1/GIP agonists as an important second-line treatment for uncomplicated type 2 diabetics who fail to meet hemoglobin A1c targets on popular first-line agents such as metformin
However, most treatments offer temporary rather than long-term relief
Numerous research efforts have focused on exploring the mechanism of endogenous antioxidants as well as developing specific exogenous antioxidants [77,78,79]
doi: 10.1016/j.ijcard.2011.12.079 50 KlatskyALFriedmanGDSidneySKippHKuboAArmstrongMA